1. Determinationof the need, scope & process for policy formulation. 2. Conductof orderly & documented consultations 3. Conduct of local research 4. Conduct of international research The National Drug Policy DOH conducted consultations from November 1986-March 1987 among the drug industry, medical professional & consumer groups which identified 7 issues. 1. A proposed essential drug list (EDL) 2. The use of generics vs brand names 3. Advertising & promotions The National Drug Policy DOH conducted consultations from November 1986-March 1987 among the drug industry, medical professional & consumer groups which identified 7 issues. 4. Procurement & self sufficiency 5. Self- medication 6. Basis for registration of pharmaceuticals 7. Pricing NDP/Generics Law
On April 30, 1987, during the
inauguration of the BFAD Laboratories in Alabang, Muntinlupa, Pres. C. Aquino announced the NDP & the government’s commitment to its implementation’ NDP/Generics Law
The Supreme Court has declared
the Generic Act of 1988 legal & constitutional.
The Generics Act was signed into a
law on Sept 13, 1988 . Implementing guidelines issued in December 1988. NDP/Generics Law
The DOH has conducted a sustained
information campaign about the law & its provisions.
After more than 15 months, enough time
has been given to prepare for the law’s implementation. NDP/Generics Law
The responsibility to comply with the law
is now with the doctors, manufacturers, drug stores & pharmacists.
The DOH will enforce the law & continue
to provide assistance & information to the public. Generics Law: RA 6675
Sec 1. Definition of terms
Sec 2. Guidelines on prescribing based on previous laws Sec 3. Additional guidelines on prescribing to implement the Generics Act oof 1988 Sec 4. Violative, Erroneous, & Impossible Prescriptions Generics Law: RA 6675
Sec 5. Violations on the part of
Dispensers & Outlets Sec 6. Monitoring & Reporting of Non-Compliance Sec 7. Administrative Sanctions Sec 8. Criminal Liabilities Generics Law : RA 6675
Sec 2. Guidelines in Prescribing
• Only validly medical, dental & veterinary practitioners are authorized to prescribe medicines
• All prescriptions must contain the name, office
address, PRC number, PTR number of the prescriber, patient’s name, age , sex & date of prescription
• For prohibited drugs, needs , S2 license, DDB Rx
form, record system following DDB requirements Sec 4. Violative Prescription
Where generic name is not written
Where the generic name is not legible & brand name which is legible is written Where the brand name is indicated & instructions added ( such as ‘ no substitution’ ) which tend to obstruct , hinder, or prevent proper generic dispensing Sec 4. Erroneous Prescription
Where the brand name precedes the
generic name Wherethe generic name is the one in parenthesis Wherethe brand name is not in the parenthesis Where more than one product is prescribed in one prescription form Sec 4. Impossible Prescription
When generic name is written & not
legible When the generic name does not correspond to the brand name When both the brand & generic names are not legible When one drug prescribed is not registered with the BFAD
Primary Prevention of Cardiovascular Disease With Atorvastatin in Type 2 Diabetes in The Collaborative Atorvastatin Diabetes Study (CARDS) : Multicentre Randomised Placebo-Controlled Trial